Literature DB >> 16966434

ZNF652, a novel zinc finger protein, interacts with the putative breast tumor suppressor CBFA2T3 to repress transcription.

Raman Kumar1, Jantina Manning, Hayley E Spendlove, Gabriel Kremmidiotis, Ross McKirdy, Jaclyn Lee, David N Millband, Kelly M Cheney, Martha R Stampfer, Prem P Dwivedi, Howard A Morris, David F Callen.   

Abstract

The transcriptional repressor CBFA2T3 is a putative breast tumor suppressor. To define the role of CBFA2T3, we used a segment of this protein as bait in a yeast two-hybrid screen and identified a novel uncharacterized protein, ZNF652. In general, primary tumors and cancer cell lines showed lower expression of ZNF652 than normal tissues. Together with the location of this gene on the long arm of chromosome 17q, a region of frequent loss of heterozygosity in cancer, these results suggest a possible role of ZNF652 in tumorigenesis. In silico analysis of this protein revealed that it contains multiple classic zinc finger domains that are predicted to bind DNA. Coimmunoprecipitation assays showed that ZNF652 strongly interacts with CBFA2T3 and this interaction occurs through the COOH-terminal 109 amino acids of ZNF652. In contrast, there was a weak interaction of ZNF652 with CBFA2T1 and CBFA2T2, the other two members of this ETO family. Transcriptional reporter assays further confirmed the strength and selectivity of the ZNF652-CBFA2T3 interaction. The transcriptional repression of growth factor independent-1 (GFI-1), a previously characterized ETO effector zinc finger protein, was shown to be enhanced by CBFA2T1, but to a lesser extent by CBFA2T2 and CBFA2T3. We therefore suggest that each of the various gene effector zinc finger proteins may specifically interact with one or more of the ETO proteins to generate a defined range of transcriptional repressor complexes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16966434     DOI: 10.1158/1541-7786.MCR-05-0249

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  21 in total

1.  Fine-mapping the 2q37 and 17q11.2-q22 loci for novel genes and sequence variants associated with a genetic predisposition to prostate cancer.

Authors:  Virpi H Laitinen; Tommi Rantapero; Daniel Fischer; Elisa M Vuorinen; Teuvo L J Tammela; Tiina Wahlfors; Johanna Schleutker
Journal:  Int J Cancer       Date:  2014-11-08       Impact factor: 7.396

2.  NEpiC: a network-assisted algorithm for epigenetic studies using mean and variance combined signals.

Authors:  Peifeng Ruan; Jing Shen; Regina M Santella; Shuigeng Zhou; Shuang Wang
Journal:  Nucleic Acids Res       Date:  2016-06-14       Impact factor: 16.971

3.  Activation of transcriptional activity of HSE by a novel mouse zinc finger protein ZNFD specifically expressed in testis.

Authors:  Fengqin Xu; Weiping Wang; Chen Lei; Qingmei Liu; Hao Qiu; Vinaydhar Muraleedharan; Bin Zhou; Hongxia Cheng; Zhongkai Huang; Weian Xu; Bichun Li; Minghua Wang
Journal:  Mol Cell Biochem       Date:  2012-01-10       Impact factor: 3.396

Review 4.  miRNAs in the pathogenesis of oncogenic human viruses.

Authors:  Zhen Lin; Erik K Flemington
Journal:  Cancer Lett       Date:  2010-10-12       Impact factor: 8.679

5.  Nuclear respiratory factor 1 transcriptomic signatures as prognostic indicators of recurring aggressive mesenchymal glioblastoma and resistance to therapy in White American females.

Authors:  Kaumudi Bhawe; Jayanta K Das; Changwon Yoo; Quentin Felty; Zhenghua Gong; Alok Deoraj; Juan P Liuzzi; Nasreen Z Ehtesham; Seyed E Hasnain; Varindera Paul Singh; Ishani Mohapatra; Ricardo Jorge Komotar; Deodutta Roy
Journal:  J Cancer Res Clin Oncol       Date:  2022-04-20       Impact factor: 4.553

6.  Gene and microRNA analysis of neutrophils from patients with polycythemia vera and essential thrombocytosis: down-regulation of micro RNA-1 and -133a.

Authors:  Stefanie Slezak; Ping Jin; Lorraine Caruccio; Jiaqiang Ren; Michael Bennett; Nausheen Zia; Sharon Adams; Ena Wang; Joao Ascensao; Geraldine Schechter; David Stroncek
Journal:  J Transl Med       Date:  2009-06-04       Impact factor: 5.531

7.  MicroRNA-155 is an Epstein-Barr virus-induced gene that modulates Epstein-Barr virus-regulated gene expression pathways.

Authors:  Qinyan Yin; Jane McBride; Claire Fewell; Michelle Lacey; Xia Wang; Zhen Lin; Jennifer Cameron; Erik K Flemington
Journal:  J Virol       Date:  2008-03-26       Impact factor: 5.103

8.  A system for detecting high impact-low frequency mutations in primary tumors and metastases.

Authors:  M Anjanappa; Y Hao; E R Simpson; P Bhat-Nakshatri; J B Nelson; S A Tersey; R G Mirmira; A A Cohen-Gadol; M R Saadatzadeh; L Li; F Fang; K P Nephew; K D Miller; Y Liu; H Nakshatri
Journal:  Oncogene       Date:  2017-09-11       Impact factor: 9.867

9.  Screening for Regulatory Variants in 460 kb Encompassing the CFTR Locus in Cystic Fibrosis Patients.

Authors:  Jenny L Kerschner; Sujana Ghosh; Alekh Paranjapye; Wilmel R Cosme; Marie-Pierre Audrézet; Miyuki Nakakuki; Hiroshi Ishiguro; Claude Férec; Johanna Rommens; Ann Harris
Journal:  J Mol Diagn       Date:  2018-10-05       Impact factor: 5.568

10.  Identification of a Novel Transcription Factor Prognostic Index for Breast Cancer.

Authors:  Junhao Liu; Zexuan Liu; Yangying Zhou; Manting Zeng; Sanshui Pan; Huan Liu; Qiong Liu; Hong Zhu
Journal:  Front Oncol       Date:  2021-06-24       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.